Parkway Life REIT

SGX: C2PU

4.010

+0.50%

Share Price in SGD. As of 30 Sep 17:04:44 SGT

Google

Make Beansprout your preferred source on Google

Add us on Google to see more of our insights in your search results

Price chart
Key Stats
Share Price Target
Beansprout Analysis

Compare REITs

Have another REIT in mind?
Select a REIT to compare with Parkway Life REIT

Market Analysis

Analyst Ratings

  • Beansprout

    05 May 2026

    BUY

    SGD 4.600

  • DBS

    13 Jul 2026

    BUY

    SGD 4.750

  • DBS Research

    13 Jul 2026

    BUY

    SGD 4.750

  • Maybank Research

    08 Apr 2026

    BUY

    SGD 4.880

  • OCBC Research

    16 Jul 2026

    BUY

    SGD 4.800

  • UOB Kay Hian

    13 May 2026

    BUY

    SGD 5.450

Opportunity Screen
Valuation
Financials
News
Announcements
Profile
  • CEO

    -

  • IPO Date

    -

  • Headquarters

    -

  • Exchange

    SGX

  • Sector

    -

  • Industry

    -

  • Employees

    -

  • Website

    -

Company description

Parkway Life REIT invests in healthcare and healthcare-related real estate in Asia-Pacific. Its portfolio includes private hospitals in Singapore and healthcare-related assets such as nursing homes and aged-care facilities in Japan and Malaysia. Revenue is generated mainly from long-term leases and rental income from healthcare operators. The REIT sits in the healthcare infrastructure value chain by owning specialised real estate used to deliver medical, hospital and eldercare services. Parkway Life REIT was listed on the SGX-ST in 2007 and is managed by Parkway Trust Management Limited.

chatbubble
Discussion

0 comments